Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 and Cancer | What Researchers Must Know

Peptide researchers may have heard of the “gastric pentadecapeptide body protection compound” or BPC-157. It has been billed by some researchers as the next big thing in tissue regeneration, potentially helping test subjects recover from sprains, muscle tears,

By Recovery & Performance Peptides Editorial Team

Peptide researchers may have heard of the “gastric pentadecapeptide body protection compound” or BPC-157. It has been billed by some researchers as the next big thing in tissue regeneration, potentially helping test subjects recover from sprains, muscle tears, and even stomach ulcers.

It seems like BPC-157 has plenty of potential.

But what about…BPC-157 and cancer?

This guide will explain everything that researchers must know about BPC-157 including its purported benefits, side effects, and its link to cancer. For those unfamiliar with BCP-157, a full overview of BPC-157 can be found below.

Buy BPC-157 from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is BPC-157?

BPC-157 is a pentadecapeptide, which is a fancy name for a series of 15 amino acids that are held together by peptide bonds. It is also commonly known as Bepecin [1], PL-10, and PL 14736 [2].

This peptide was first identified in the Journal of Physiology in 1993 [3]. It is not found naturally in nature and is made in a lab, so it is classified as a synthetic peptide.

But it isn't really synthetic—it’s derived directly from a protein that is found in the human gut. It is basically one part of a protein that is naturally produced in the digestive system [4].

There's some strong evidence that BPC-157 has beneficial effects on test subjects, especially in terms of healing and regeneration. The “BPC” in the name, which stands for “body protecting compound”, describes exactly what BPC purportedly does – protects and heals tissue [4].

BPC-157 and Cancer | The Reality

What about its application to cancer? Can it help? Does it hurt?

To start, let's be clear that there has not been much research looking at the effects of BPC-157 on cancer, so our knowledge is very limited.

At this time, the overall effects of BPC-157 on cancer are not known. BPC-157 is certainly NOT a cancer cure. At all.

However, the research that does exist is worth a bit of exploration…

Possible Contributor to Cancer

One study investigated the role of BPC-157 on blood vessels. It found that BPC was a very strong angiomodulatory agent, which means it affects how blood vessels are made [5]. The research suggests that BPC may help to heal tissue by increasing blood flow. It does this through angiogenesis and vasculogenesis, which are big terms that basically mean helping to create new arteries and veins.

But researchers also point out that blood vessels are involved in the creation of tumors as well. Some researchers speculate that, by helping create new blood vessels to tissue, BPC-157 could also help supply the blood that supports cancerous tissue growth [5].

It is important to note that no studies show that BPC-157 could support cancerous tissue growth.

While some researchers speculate that it could play a role in supporting cancerous tissue growth [5], there have not been any studies to date that have linked BPC to tumor growth [4].

Cancer Prevention

On the other hand, some researchers have suggested that BPC-157 could actually help to prevent certain forms of cancer.

These findings are far from conclusive.

Still, some drugs, like haloperidol, which is used to treat mental disorders like schizophrenia, have been found to cause damage to the stomach lining [6]. Stomach lining damage, including lesions and ulcers, can sometimes become cancerous [7].

One study found that BPC-157 could be useful in preventing lesions that form in the lining of the stomach as a result of taking haloperidol [8]. In the study, mice were given haloperidol. They formed stomach lesions. However, the researchers found that BPC-157 significantly reduced the size of the stomach lesions [8].

By helping to prevent damage to the stomach that can sometimes lead to cancerous tumors, BPC-157 may help to reduce the chances of developing cancerous stomach ulcers.

In another study, researchers found that BPC-157 had an inhibitory effect on skin cancer cells in humans. That means that there is some very preliminary evidence that it can slow down skin cancer growth [9].

Again, the research is not settled yet, but some initial signs suggest BPC-157 isn't a net negative when talking about cancer.

Treating Cancer Side-Effects

There is research showing that BPC-157 may help treat some of the side effects of the drugs used to treat cancer.

One popular chemotherapy drug is cyclophosphamide. Cyclophosphamide is effective at killing cancer cells, but it also has several unfortunate side effects. One of those is causing lesions in the stomach [10].

BPC-157 to the rescue.

One study looked at the effect of BPC-157 in rats that were given cyclophosphamide [10]. The study found that rats who were also given BPC had much smaller stomach lesions than rats that were not given the peptide.

The researchers concluded that BPC-157 is a “very safe anti-ulcer peptide.” The study suggests that people might be able to use this peptide to reduce the damage that some chemotherapy drugs do to the digestive system.

It might also be effective in treating cancer cachexia.

Cachexia, also known as wasting syndrome, is a condition where a person loses body mass, including both muscle and fat. It's usually caused by an underlying medical condition like cancer or AIDS [11].

About half of all cancer patients suffer from cachexia at some point. That number rises to 80% in terminal cancer patients [11]. Cachexia is a problem because it causes lots of other complications, including death. Some estimate that 20% of cancer deaths actually result from cachexia [12].

The exact mechanism is not clear, but some studies have found that BCP-157 can help in the treatment of cachexia resulting from cancer [12].

Does BPC-157 Actually Work?

While there isn’t a lot of research on how BPC-157 interacts with cancer, it appears that it could be useful in preventing and addressing the side effects of cancer. But we still don’t know. Nothing is proven as of yet.

The effects of BPC on wound healing are much clearer:

It absolutely can help test subjects regenerate tissue.

Lots of evidence has found that it can help to improve inflammatory bowel disease [13], the ability for ligaments [14] and tendons to heal [14, 15], for muscles to heal [4], and for bones to heal [16]. It also appears to help skin regrow [17] and some research in rats also suggests that it can regenerate spinal tissue [18].

It also appears that it could be effective in a number of different delivery methods. In rat trials, benefits for healing were found when BPC-157 was taken:

Orally, in pill form;

Orally, dissolved in drinking water;

Topically, in a cream;

Topically, in a dermal patch

Injected using a syringe [4]

BPC-157 Benefits and Uses

What are the purported benefits of BPC-157?

Well, there are many. Some are better supported in the research than others, but here's a big list of the benefits one could find from using it:

Heals of tendons and ligaments: Some researchers have suggested that BPC-157 could one day be considered as an alternative to reconstructive surgery [15, 22].

Repairs damage of painkillers: Some drugs, like Advil and Ibuprofen, can damage the gut lining. Researchers have said that BPC-157 may be an “antidote” to these effects [19].

Reduces symptoms of inflammatory bowel disease: Studies have shown that it can effectively repair damage from inflammatory bowel disease in rodents, and may do the same in human test subjects [20].

Help cure periodontitis: Studies in rats show promise for the ability of BPC-157 to help repair tissue in the mouth and may be a candidate in treating periodontal disease [23].

Accelerate bone healing: Much research has shown that BPC-157 can help speed up the recovery of damage to bones and the attachment of ligaments to bones [4].

Has anti-ulcer effects: As described above, BPC-157 has demonstrated that it has potent rejuvenation properties for the digestive system including in healing and preventing ulcers [20].

Wound healing: Some research also demonstrates that it can accelerate skin and wound healing, including wounds from burns [17].

BPC-157 Side Effects

Okay, there are lots of potential benefits of BPC-157… but what are the side effects?

The side effects of BPC-157 seem to be minimal. It’s generally considered to be a safe substance because it is made directly from proteins that we already produce in our bodies [4].

In fact, research in several trials has found no side effects in humans at all [20, 21].

However, there has also been very little research on BPC-157 use in humans, so scientists have not had a chance to determine its toxicity.

We don’t have any information on whether there are side effects for prolonged use. It could be that some side effects have not yet been found by researchers.

Some side effects that are common in BPC-157 and other peptides include:

Headache

Dizziness/fatigue

Slightly elevated blood pressure

Nausea

Redness/pain in the area of injection

Increase in appetite

While many test subjects have not experienced any side effects as a result of BPC-157, it is important for researchers to understand the risks and how to potentially mitigate them.

Where to Buy BPC-157 Online? | 2024 Edition

There are many sites where researchers can buy BPC-157 online. However, peptide quality can vary drastically from one vendor to the next.

To assist researchers, our team has reviewed the top peptide vendors and rated them according to their quality, prices, and reliability.

Here are the top research peptides vendors to purchase BPC-157 from:

Limitless Life

Limitless Life is our top-rated research peptides vendor here at Peptides.org. This is especially true when talking about BPC-157.

Here’s what this vendor does exceptionally well:

Third-Purity Testing: Limitless Life is focused on one thing: producing the purest peptides around. As such, this vendor works with multiple third-party labs that offer purity testing via HPLC-MS analysis. They run every batch of research peptides they producing through this testing process. This ensures Limitless Life only offers the purest research peptides, like BPC-157.

Rapid Shipping Options: The majority of orders from Limitless Life ship the same day they are placed. This ensures researchers can get to work quickly. They're able to do so by offer FedEx two-day shipping standard. They also have overnight options available for domestic researchers. Lastly, Limitless Life does ship internationally to researchers around the globe.

Cheap Shipping Insurance: Limitless Life is unique in that they have shipping insurance available to researchers. This offers peace of mind and confidence to the research community.

Premier Service and Support: Limitless Life offers some of the best phone and email support in the industry. With 7-days a week support available to researchers, no question will go unread with this company.

Multiple Payment Options: Limitless Life also takes credit cards, which is important. They also have e-check, Cash App, and cryptocurrency payments. Many of these payment options offer a 10% discount to researchers, too.

For researchers looking for BPC-157 nasal spray and/or capsules, Limitless Life offers both unique formulations:

BPC-157 + TB-500 Nasal Spray

BPC-157 Capsules

Finally, all qualified researchers can get an additional 10% discount on the next order when buying from Limitless Life. Simply click the button below and make sure to add this code:

peptidesorg10

Xcel Peptides

Xcel Peptides is another great option for researchers looking for high-quality BPC-157 and more.

Here are a few things this company does well.

Purity Testing: Xcel Peptides takes all BPC-157 batches and gets them tested by third-party labs to ensure purity. This allows the company to produce high-quality and safe BPC-157 for the research community.

Responsive Support and Service: Researchers have access to a dedicated support team when working with Xcel Peptides. All peptide or order-related inquiries can expect a response in around one business day.

Quick Shipping Options: Xcel Peptides strives to offer same-day or next-day shipping on all peptide orders. In doing so, the company gets researchers their peptides quickly and efficiently.

Furthermore, Xcel Peptides offers stable BPC-157 capsules and a BPC-157 + TB-500 blend.

Buy research peptides from Polaris Peptides today...

BPC-157 and Bacteriostatic Water

When it comes to reconstituting, injecting, and storing BPC-157, a researcher must have the requisite supplies for proper handling.

Sterile vials, bacteriostatic water, and more are just a few of the materials needed.

The experts at Peptides.org are pleased to give our top recommendation for the purchase of supplies required for peptide research.

Click here to learn more.

BPC-157 and Cancer | The Verdict

So, to recap, what does the research say about BPC-157 and cancer?

Well, it’s not yet clear. The research about BPC-157 and cancer is still in its infancy, so we don't know exactly what the effects are.

Much of the research on BPC-157 has also been done with rodents, which limits our understanding of what effects this peptide may have in human test subjects. For that reason, we don’t know much about BPC-157 and cancer.

For researchers looking to source the highest-quality BPC-157 from a reputable company, check out our top-rated vendor.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Injectable BPC-157 Dosing Protocols

Injectable administration represents the most common approach for BPC-157 use, particularly for localized healing applications. Understanding proper dosing helps ensure optimal results while minimizing any potential for adverse effects. The dose range for BPC-157 shows remarkable flexibility in animal research. Studies demonstrate effectiveness across a 100-fold dose range, from 0.01 mg per kg to 1 mg per kg of body weight. This wide therapeutic window suggests the peptide maintains benefits without requiring precise dosing, though most human protocols settle within the standard range. For a 175-pound individual, the commonly used doses translate to approximately 0.0016 mg per pound at the lower end and 0.0032 mg per pound at the higher end. Most protocols split the difference, using 0.25 mg to 0.5 mg total daily regardless of body weight, based on practical experience rather than strict weight-based calculations. The tendency to overthink BPC-157 dosing seems common among newcomers. The animal research shows such a wide effective range that precise calculations matter less than consistency. Pick a dose in the standard range, use it consistently, and give the protocol adequate time to work. Constantly adjusting doses probably does more to confuse results than optimize them. Injection site selection depends on the application. For localized healing, injecting near the injury site delivers higher peptide concentrations to target tissues. The peptide does demonstrate systemic m…
SIDE EFFECTS

BPC-157 Side Effects, Risks, and Unknowns

When you look into BPC-157 side effects, this is what you’ll find: Research suggests that taking the peptide has potential risks, due to unregulated manufacturing and contamination, as well as a lack of clinical safety data on people. The fact that the risks are unknown is a huge part of the overall picture—and that’s sometimes disguised by sellers or influencers pointing to “successful” research. For example, you may hear about a 2025 pilot study (considered preliminary research), which found that BPC-157 infusions were well-tolerated with no side effects. But here’s the catch: This study was done on only two people, a 58-year-old man and a 68-year-old woman. BPC-157 is also not an FDA-approved treatment, and they've noted safety concerns surrounding this peptide, citing that it may contain impurities and may trigger an unwanted immune system response that could be dangerous. Because there's no safety data, the FDA says it may be harmful to people using it. The point is, we just don’t know, and there's so much more research that needs to be done. Beyond the lack of research on BPC-157, there are concerns over how people are accessing peptides in general. Gray-market peptides can create risks beyond the peptide itself, raising concerns over product quality, purity, and inconsistent formulation. In sum: Uncertain risks plus an unclear benefit equals a trade-off that’s just not worth it.
02

Question drills

Open a question for its connected answer.

01What If I Start BPC-157 Two Weeks After Surgery—Is It Too Late?+

You'll see diminishing returns. The peptide's primary mechanism—modulating collagen architecture during the proliferative phase—peaks between days 4–14 post-injury. By week two, collagen deposition patterns are largely set. You may still see modest improvements in wound closure speed and inflammation reduction, but the anti-keloid effect that makes BPC-157 unique is mostly lost. For future injuries, start immediately post-op—ideally within 24 hours—to capture the remodeling window when fibroblasts are still establishing collagen alignment.

SOURCE / realpeptides.co ↗
02What If I'm Using BPC-157 Alongside Other Peptides Like Thymalin or MK-677?+

BPC-157 has no known negative interactions with immune-modulating peptides like Thymalin or growth hormone secretagogues like MK-677. In fact, combining BPC-157 with Thymalin may support systemic immune function during tissue repair, which becomes increasingly relevant in older populations where chronic low-grade inflammation (inflammaging) impairs healing. Maintain separate injection sites and stagger administration by at least 4–6 hours to avoid localised peptide interference.

SOURCE / realpeptides.co ↗
03What If I Try BPC-157 for SIBO Without Addressing the Root Cause?+

BPC-157 won't eradicate bacterial overgrowth if the underlying motility disorder, anatomical obstruction, or immune deficiency remains untreated. SIBO recurs in 40–45% of patients within 9 months after rifaximin precisely because the predisposing factor wasn't corrected. If you're considering BPC-157 studied SIBO protocols, identify your SIBO subtype first. Hydrogen-dominant (from carbohydrate fermentation), methane-dominant (from Methanobrevibacter overgrowth), or hydrogen sulfide-dominant. Each requires different antimicrobial strategies, and BPC-157's mucosal repair effects won't compensate for persistent bacterial replication if motility remains impaired.

SOURCE / realpeptides.co ↗
04What If Nerve Fiber Density Doesn't Improve After Four Weeks?+

The ARA-290 sarcoidosis trial measured improvement at four weeks, but the timeline for vascular remodeling (BPC-157's proposed mechanism) may extend beyond that window. Animal studies showing nerve recovery used 2–4 week protocols. If using BPC-157 for ischemic neuropathy research, functional assessments (nerve conduction velocity, sensory testing) may lag behind histological changes by several weeks. Absence of improvement at four weeks doesn't necessarily indicate mechanism failure. Diabetic neuropathy progression occurs over months to years, and reversal timelines may be similarly protracted.

SOURCE / realpeptides.co ↗
05What If I Want to Use BPC-157 After ACL Reconstruction Surgery?+

Contact your orthopedic surgeon before initiating any peptide protocol post-operatively. BPC-157 is not FDA-approved and has no established human safety data in post-surgical contexts. Your surgeon needs to document any non-standard interventions you pursue, particularly if complications arise that require revision surgery. Animal models suggest potential benefit in graft integration, but human application introduces variables (immune response to compounded peptides, infection risk from non-sterile vials, interaction with prescribed analgesics or antibiotics) that research models don't account for.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Research Design Considerations

Renal BPC-157 studies require attention to route-of-administration kinetics. Oral BPC-157 reaches peak plasma concentrations within 30–60 min and is detectable in renal cortex within 2h by HPLC/MS — supporting both i.p./s.c. injection protocols and drinking water/gavage paradigms depending on research question. Creatinine-based GFR estimation in rodents requires single-injection FITC-inulin or iohexol clearance for accuracy (urinary creatinine-to-plasma creatinine ratios are confounded by rodent tubular creatinine secretion); the plasma clearance slope method gives more reliable GFR data. Albuminuria quantification should use species-specific ELISA kits (rat/mouse albumin-specific, not human), normalised to urinary creatinine or cystatin C. Histological injury scoring (tubular necrosis, cast formation, interstitial inflammation, glomerulosclerosis) should follow validated scoring systems: the semi-quantitative AKI score of Jaber et al. (0–4 per parameter per cortical/medullary zone) or the QUANTIFY digital pathology platform for unbiased area-percentage measurements. Blinding of histological analysis is essential given the subjective nature of semi-quantitative injury scoring.

RESEARCH

BPC-157 and Eye Research: Retinal Protection, Ocular Angiogenesis and Optic Nerve Biology UK 2026

⚠️ Research Use Only: BPC-157 is an experimental synthetic peptide supplied strictly for laboratory and preclinical research. It is not approved for human therapeutic use, is not a licensed medicine, and must not be administered to humans. All content below describes peer-reviewed preclinical science only.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Comparison with Other Tissue-Repair Peptides in Immune Biology

Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but throu…

Comparison

Comparison with Other Research Peptides

Compared to peptides such as CJC-1295 and Tesamorelin, which primarily influence growth hormone release, BPC-157’s focus is on local tissue healing and regeneration. While CJC-129…

Comparison

Local Versus Systemic Injection

For specific injuries, injecting 1 to 2 inches from the injury site delivers high local concentration while still providing systemic benefits. For vagal and neurological effects, …

Continue reading

Related articles